QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 SCFFBXW7/GSK3 beta-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells 期刊论文 CANCER RESEARCH, 2019, 卷号: 79, 期号: 17, 页码: 4387-4398 作者:  Kuai, Xiaoling;  Li, Long;  Chen, Ran;  Wang, Kangjunjie;  Chen, Min 收藏  |  浏览/下载：18/0  |  提交时间：2020/07/01 Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes 期刊论文 NATURE CELL BIOLOGY, 2019, 卷号: 21, 期号: 8, 页码: 1015-+ 作者:  Sun, Lulu;  Wang, Yuqing;  Cen, Jin;  Ma, Xiaolong;  Cui, Lei 收藏  |  浏览/下载：26/0  |  提交时间：2020/07/01 G-quadruplex and duplex DNA binding studies of novel Ruthenium(II) complexes containing ascididemin ligands 期刊论文 JOURNAL OF INORGANIC BIOCHEMISTRY, 2019, 卷号: 196, 页码: 10 作者:  Wumaier, Maierhaba;  Shi, Jing-Jing;  Yao, Tian-Ming;  Hu, Xiao-Chun;  Gao, Ru-Ru 收藏  |  浏览/下载：11/0  |  提交时间：2020/07/01 Ruthenium complexes  G-quadruplex  Duplex DNA  Ascididemin   EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 页码: 15 作者:  Qin, Jianhua;  Liu, Yang;  Yin, Yalei;  Sun, Mingju;  Zhan, Xi 收藏  |  浏览/下载：107/0  |  提交时间：2019/06/20 Bromodomain  JQ1  MAPK pathway  MYC  EGFR mutation  Sorafenib   Egfr signaling confers resistance to bet inhibition in hepatocellular carcinoma through stabilizing oncogenic myc 期刊论文 Journal of experimental & clinical cancer research, 2019, 卷号: 38, 页码: 15 作者:  Yin, Yalei;  Sun, Mingju;  Zhan, Xi;  Wu, Changqing;  Geng, Pengyu 收藏  |  浏览/下载：137/0  |  提交时间：2019/05/08 Bromodomain  Jq1  Mapk pathway  Myc  Egfr mutation  Sorafenib   Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis 期刊论文 CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 页码: 1318-1330 作者:  Hu, Li-Peng;  Zhang, Xiao-Xin;  Jiang, Shu-Heng;  Tao, Ling-Ye;  Li, Qing 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/02 adenosine triphosphate  ar c118925xx  gemcitabine  glucose transporter 1  hypoxia inducible factor 1alpha  Myc protein  platelet derived growth factor beta receptor  platelet derived growth factor receptor  protein kinase Yes  purinergic P2Y receptor antagonist  purinergic P2Y2 receptor  unclassified drug  Yes1 protein, Akt signaling  animal experiment  animal model  animal tissue  Article  cancer inhibition  cancer prognosis  cancer staging  controlled study  drug potentiation  glycolysis  human  human cell  human tissue  inflammation  lymph node metastasis  male  mouse  mouse model  nonhuman  overall survival  pancreas adenocarcinoma  pancreatic ductal carcinoma cell line  Pi3K/Akt signaling  priority journal  RNA sequence  tumor classification  tumor differentiation  tumor microenvironment  tumor volume  tumor xenograft   EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38 作者:  Yin, Yalei;  Sun, Mingju;  Zhan, Xi;  Wu, Changqing;  Geng, Pengyu 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Bromodomain  JQ1  MAPK pathway  MYC  EGFR mutation  Sorafenib   Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo 期刊论文 ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 6, 页码: 5012-5022 作者:  Wang, Jiansong;  Ji, Huaijun;  Zhu, Qiang;  Yu, Xinshuang;  Du, Juan 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/11 esophageal squamous cell carcinoma  chemoresistance  apoptosis  c-Myc  B  lymphoma Mo-MLV insertion region 1 homolog  melanoma nuclear protein 18   JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways 期刊论文 JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2019, 卷号: 48, 期号: 1, 页码: 43-51 作者:  Liu, Xiaojing;  Wu, Haitao;  Huang, Ping;  Zhang, Fenghe 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 c-Myc  EGFR  JQ1  PI3K inhibitor  salivary adenoid cystic carcinoma